Anlotinib in combination with pembrolizumab for low-grade myofibroblastic sarcoma of the pancreas: A case report

Rong-Ting Wu, Ji-Cheng Zhang, Cheng-Nan Fang, Xiao-Yu Qi, Jin-Fei Qiao, Ping Li, Li Su · 2023

Read Anlotinib in combination with pembrolizumab for low-grade myofibroblastic sarcoma of the pancreas: A case report by Rong-Ting Wu, Ji-Cheng Zhang, Cheng-Nan Fang, Xiao-Yu Qi, Jin-Fei Qiao, Ping Li, Li Su (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10731194.txt.

Description

Rong-Ting Wu and co-authors report a case of a rare, low-grade sarcoma in the pancreas that returned after surgery and spread. Very few cases of this tumor type in the pancreas exist in print. The mass was found on a routine check, and scans plus tissue tests confirmed the diagnosis, as the 2023 report tells.

Standard treatment failed against the returned, spread disease. With family consent, the team tried a pair of drugs: one that starves tumor blood supply, and one immune drug. Scans and symptoms later showed a fairly good response to the pair. The authors also review past cases to sharpen how this rare tumor is spotted, and offer the drug pair as a strategy worth testing further.

Catalog record

CREATORRong-Ting Wu, Ji-Cheng Zhang, Cheng-Nan Fang, Xiao-Yu Qi, Jin-Fei Qiao, Ping Li, Li Su
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10731194

Browse the full library · About the Tower of Babel